FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016942107> ?p ?o ?g. }

• W2016942107 endingPage "851" @default.
• W2016942107 startingPage "845" @default.
• W2016942107 abstract "High-risk subjects with elevated C-reactive protein (CRP) are at high risk for cardiovascular events and frequently require potent statins or combined lipid-lowering therapy to achieve lipid targets and decrease inflammation. Our study aimed at evaluating the effects of three lipid-modifying therapies on LDL-cholesterol, CRP levels and markers of cholesterol absorption and synthesis.A prospective intervention study was performed in high cardiovascular risk individuals receiving atorvastatin 10mg daily for four weeks. Those with CRP≥2.0mg/L were randomized to another four-week treatment period with atorvastatin 40mg, ezetimibe 10mg or the combination of atorvastatin 40mg / ezetimibe 10mg. Lipids, markers of cholesterol absorption (campesterol and β-sitosterol), and synthesis (desmosterol), as well as CRP were quantified at baseline and end of study.One hundred and twenty two individuals were included. Atorvastatin alone or combined with ezetimibe reduced both LDL-cholesterol and CRP (P<0.002 vs. baseline; Wilcoxon); ezetimibe did not modify CRP. Ezetimibe-based therapies reduced absorption markers and their ratios to cholesterol (P<0.0001 vs. baseline, for all; Wilcoxon), whereas atorvastatin alone increased campesterol/cholesterol and β-sitosterol/cholesterol ratios (P<0.05 vs. baseline; Wilcoxon). In addition, ezetimibe also increased desmosterol and desmosterol/cholesterol ratio (P<0.0001 vs. baseline; Wilcoxon).These results contribute to understanding the link between cellular cholesterol homeostasis, inflammation and lipid-modifying therapies. Our findings highlight the broader benefit of combined therapy with a potent statin and ezetimibe decreasing inflammation, and preventing increase in cholesterol biosynthesis, an effect not observed with ezetimibe alone." @default.
• W2016942107 created "2016-06-24" @default.
• W2016942107 creator A5001452070 @default.
• W2016942107 creator A5016481536 @default.
• W2016942107 creator A5021986808 @default.
• W2016942107 creator A5024340821 @default.
• W2016942107 creator A5030391700 @default.
• W2016942107 creator A5051549250 @default.
• W2016942107 creator A5069355026 @default.
• W2016942107 creator A5074047152 @default.
• W2016942107 creator A5074496928 @default.
• W2016942107 creator A5088548722 @default.
• W2016942107 date "2013-05-01" @default.
• W2016942107 modified "2023-10-02" @default.
• W2016942107 title "Effects of ezetimibe on markers of synthesis and absorption of cholesterol in high-risk patients with elevated C-reactive protein" @default.
• W2016942107 cites W127809968 @default.
• W2016942107 cites W1964532888 @default.
• W2016942107 cites W1988709334 @default.
• W2016942107 cites W2003098602 @default.
• W2016942107 cites W2008910697 @default.
• W2016942107 cites W2020687765 @default.
• W2016942107 cites W2027168652 @default.
• W2016942107 cites W2027415701 @default.
• W2016942107 cites W2037121067 @default.
• W2016942107 cites W2062160470 @default.
• W2016942107 cites W2062179198 @default.
• W2016942107 cites W2080241928 @default.
• W2016942107 cites W2084242433 @default.
• W2016942107 cites W2096079570 @default.
• W2016942107 cites W2097245088 @default.
• W2016942107 cites W2103825268 @default.
• W2016942107 cites W2111333591 @default.
• W2016942107 cites W2116404316 @default.
• W2016942107 cites W2116416944 @default.
• W2016942107 cites W2120289695 @default.
• W2016942107 cites W2135589992 @default.
• W2016942107 cites W2137983259 @default.
• W2016942107 cites W2144896295 @default.
• W2016942107 cites W2147426665 @default.
• W2016942107 cites W2150547160 @default.
• W2016942107 cites W2153014921 @default.
• W2016942107 cites W2163448195 @default.
• W2016942107 cites W2164089346 @default.
• W2016942107 cites W2167045683 @default.
• W2016942107 cites W2231069932 @default.
• W2016942107 cites W2330863267 @default.
• W2016942107 cites W4238251256 @default.
• W2016942107 doi "https://doi.org/10.1016/j.lfs.2013.02.018" @default.
• W2016942107 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23507424" @default.
• W2016942107 hasPublicationYear "2013" @default.
• W2016942107 type Work @default.
• W2016942107 sameAs 2016942107 @default.
• W2016942107 citedByCount "22" @default.
• W2016942107 countsByYear W20169421072014 @default.
• W2016942107 countsByYear W20169421072015 @default.
• W2016942107 countsByYear W20169421072017 @default.
• W2016942107 countsByYear W20169421072018 @default.
• W2016942107 countsByYear W20169421072019 @default.
• W2016942107 countsByYear W20169421072020 @default.
• W2016942107 countsByYear W20169421072021 @default.
• W2016942107 countsByYear W20169421072022 @default.
• W2016942107 countsByYear W20169421072023 @default.
• W2016942107 crossrefType "journal-article" @default.
• W2016942107 hasAuthorship W2016942107A5001452070 @default.
• W2016942107 hasAuthorship W2016942107A5016481536 @default.
• W2016942107 hasAuthorship W2016942107A5021986808 @default.
• W2016942107 hasAuthorship W2016942107A5024340821 @default.
• W2016942107 hasAuthorship W2016942107A5030391700 @default.
• W2016942107 hasAuthorship W2016942107A5051549250 @default.
• W2016942107 hasAuthorship W2016942107A5069355026 @default.
• W2016942107 hasAuthorship W2016942107A5074047152 @default.
• W2016942107 hasAuthorship W2016942107A5074496928 @default.
• W2016942107 hasAuthorship W2016942107A5088548722 @default.
• W2016942107 hasBestOaLocation W20169421071 @default.
• W2016942107 hasConcept C126322002 @default.
• W2016942107 hasConcept C134018914 @default.
• W2016942107 hasConcept C2776839432 @default.
• W2016942107 hasConcept C2776914184 @default.
• W2016942107 hasConcept C2777085297 @default.
• W2016942107 hasConcept C2777482532 @default.
• W2016942107 hasConcept C2778163477 @default.
• W2016942107 hasConcept C2778657065 @default.
• W2016942107 hasConcept C2778718757 @default.
• W2016942107 hasConcept C2780022283 @default.
• W2016942107 hasConcept C2781195455 @default.
• W2016942107 hasConcept C2781471481 @default.
• W2016942107 hasConcept C71924100 @default.
• W2016942107 hasConcept C90924648 @default.
• W2016942107 hasConcept C98274493 @default.
• W2016942107 hasConceptScore W2016942107C126322002 @default.
• W2016942107 hasConceptScore W2016942107C134018914 @default.
• W2016942107 hasConceptScore W2016942107C2776839432 @default.
• W2016942107 hasConceptScore W2016942107C2776914184 @default.
• W2016942107 hasConceptScore W2016942107C2777085297 @default.
• W2016942107 hasConceptScore W2016942107C2777482532 @default.
• W2016942107 hasConceptScore W2016942107C2778163477 @default.
• W2016942107 hasConceptScore W2016942107C2778657065 @default.
• W2016942107 hasConceptScore W2016942107C2778718757 @default.

• next